Company Filing History:
Years Active: 2019-2021
Title: Shigeru Chiba: Innovator in Therapeutic Agents and Medical Devices
Introduction
Shigeru Chiba is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the fields of medical therapeutics and device engineering. With a total of three patents to his name, Chiba's work focuses on innovative solutions for complex medical challenges.
Latest Patents
Chiba's latest patents include a therapeutic agent for tumors identified by phosphorylation of proto-oncogene protein belonging to the VAV family. This invention provides a therapeutic agent for various tumors, including angioimmunoblastic T-cell lymphoma (AITL), which is classified as an orphan disease. The active ingredient in this therapeutic agent is dasatinib or a prodrug thereof, along with its pharmacologically acceptable salts, hydrates, or solvates.
Another significant patent is for a locking member, mixing tip, and double syringe. This invention features a locking member that secures a mixing nozzle to a cartridge containing two syringes. The mixing nozzle is designed to mix materials from both syringes as they are discharged. The locking member includes a support rod that is displaceable in a direction orthogonal to the nozzle's extension, along with engaging parts that interact with horizontal components on the cartridge.
Career Highlights
Chiba has worked with esteemed institutions such as the University of Tsukuba and Gc Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Chiba has collaborated with notable colleagues, including Mamiko Yanagimoto and Shinichi Kojima. Their combined expertise has fostered a productive environment for innovation and development in their respective fields.
Conclusion
Shigeru Chiba's contributions to medical therapeutics and device engineering highlight his role as a significant inventor. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.